RXD News and Press, ProShares UltraShort Health Care From 02/10/21

The pandemic has sped up structural trends that are benefiting sectors such as technology and healthcare - and we believe these trends are not fully priced in. Rising inflation expectations have driven up U.S. 10-year Treasury yields but to a lesser degree than in the past, in line wi...

2020 was a busy year for global healthcare with unprecedented efforts to develop vaccines, treatments, and diagnostics for COVID-19. Deal flow in the sector continued to gain momentum in 2020, with M&A transactions and product licensing deals totalling five-year highs as large-cap...

We share three key lessons we learned from 2020 – and how they inform our 2021 outlook. The UK and European Union agreed on a trade deal. The U.S. launched a new $900 billion fiscal package amid climbing Covid hospitalizations and deaths. This week’s U.S. nonfarm pay...

Health Care sector has been resilient during the COVID-19 pandemic. Medical Devices companies have been most impacted due to the decline in elective surgeries. Health Care will continue to be driven by (1) demographic, and (2) innovation tailwinds. For further details see: ...

By Nick Kalivas, Senior Equity Product Strategist Health care presents the opportunity to invest in companies that are constantly innovating to improve quality of life and raise productivity. When thinking about growth, many investors default to technology, noting companies like Am...

By Vinay Thapar The healthcare sector has been a reliable safe haven during even the most challenging markets. But the novel coronavirus panic is raising questions about its resilience. By looking beyond the pandemic at changes sweeping the industry, investors can find defensive healthcare...

The global response to the spread of COVID-19 has sparked an unprecedented decline in economic activity, and no industry is immune. However, the healthcare industry appears far more protected than most other sectors from coronavirus-related economic disruption. A Spectrum of Impact The h...

Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to start the year. This continues their impressive streak from 2019. But are the current tech valuations sustainable? In a recent mark...

By Vinay Thapar and Frank Caruso US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. But investors can find good opportunities in the sector in companies with strong long-term business drivers that are relatively immune to ...

By Michelle Borré, CFA, Head of Fundamental Alternative Strategies , and Brian Giesen, CFA, Intermediate Research Analyst Restrictions on the pricing of drugs delivered in doctors' offices and hospitals could have significant investment implications. The Trump Administration is...